Astrana Health, Inc.
ASTH
$23.18
$0.140.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.22M | 2.58M | 2.31M | 5.55M | 2.75M |
| Total Other Revenue | 940.83M | 652.23M | 618.08M | 659.66M | 475.96M |
| Total Revenue | 956.05M | 654.81M | 620.39M | 665.21M | 478.71M |
| Cost of Revenue | 858.86M | 576.84M | 549.06M | 614.73M | 405.22M |
| Gross Profit | 97.19M | 77.97M | 71.33M | 50.48M | 73.49M |
| SG&A Expenses | 52.09M | 50.73M | 42.49M | 41.63M | 37.80M |
| Depreciation & Amortization | 15.60M | 6.90M | 6.85M | 8.13M | 7.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 926.54M | 634.47M | 598.40M | 664.49M | 450.29M |
| Operating Income | 29.51M | 20.34M | 21.99M | 720.00K | 28.43M |
| Income Before Tax | 5.67M | 16.83M | 9.60M | -1.90M | 26.81M |
| Income Tax Expenses | 4.59M | 6.61M | 3.38M | 5.88M | 7.83M |
| Earnings from Continuing Operations | 1.08M | 10.22M | 6.22M | -7.78M | 18.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -704.00K | -793.00K | 471.00K | 826.00K | -2.89M |
| Net Income | 373.00K | 9.42M | 6.69M | -6.95M | 16.09M |
| EBIT | 29.51M | 20.34M | 21.99M | 720.00K | 28.43M |
| EBITDA | 45.11M | 27.24M | 28.84M | 8.85M | 35.69M |
| EPS Basic | 0.01 | 0.19 | 0.14 | -0.15 | 0.34 |
| Normalized Basic EPS | 0.20 | 0.20 | 0.15 | 0.01 | 0.30 |
| EPS Diluted | 0.01 | 0.19 | 0.14 | -0.15 | 0.33 |
| Normalized Diluted EPS | 0.20 | 0.20 | 0.15 | 0.01 | 0.29 |
| Average Basic Shares Outstanding | 49.22M | 49.19M | 48.47M | 46.34M | 47.69M |
| Average Diluted Shares Outstanding | 49.47M | 49.47M | 48.85M | 46.34M | 48.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 8.26% | 81.52% | -- | -- |